Entities / Company
Celgene.
American biopharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 52
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Corporate news includes the acquisition of Vidya Therapeutics by Processa Pharmaceuticals, the $7.2 billion acquisition of Receptos by Celgene, and updates regarding Gujrathi's professional history with BMS.Some support1 report
-
Bristol-Myers Squibb has taken ownership of Celgene's drug.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Celgene this week
News at the entities that move Celgene most-
Bristol-Myers Squibb StructuralBristol-Myers Squibb and AbbVie secured regulatory approval for a therapy in the US.Moves Celgene
-
Novartis Mentioned togetherSean Maenpaa, with experience at Novartis and Celgene, was appointed SVP Business Development at Clovis Oncology.Moves Celgene
-
Johnson & Johnson OperationalJohnson & Johnson was referenced in a recent news report concerning New York City.Moves Celgene
Connections
The 4 strongest of 52, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Bristol-Myers Squibb Structural
Bristol-Myers Squibb has acquired Celgene, leading to ongoing integration and associated litigation risk.
-
Novartis Mentioned together
The entities are co-mentioned as companies operating within the competitive pharmaceutical sector.
-
Asit Parikh Structural
Asit Parikh held a former executive position at Celgene.
-
Johnson & Johnson Operational
J&J and Celgene operate within the same biopharmaceutical sector.